Olema Pharmaceuticals, Inc. OLMA Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Olema Pharmaceuticals, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Olema Pharmaceuticals, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Olema Pharmaceuticals, Inc.'s current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Olema Pharmaceuticals, Inc.'s current ratio?
- Olema Pharmaceuticals, Inc. (OLMA) reported current ratio of 10.9× in Q1 2026.
- How has Olema Pharmaceuticals, Inc.'s current ratio changed year-over-year?
- Olema Pharmaceuticals, Inc.'s current ratio decreased by 28.5% year-over-year, from 15.2× to 10.9×.
- What is the long-term trend for Olema Pharmaceuticals, Inc.'s current ratio?
- Over 5 years (2020 to 2025), Olema Pharmaceuticals, Inc.'s current ratio has grown at a -33.2% compound annual growth rate (CAGR), from 74.6× to 10×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.